Skip to main content

Web Exclusives

Health Policy and Reform
HHS Takes Aim at Prior Authorizations
Read More
Online First
FDA Approvals
FDA OKs Revumenib for Relapsed, Refractory Acute Leukemia With KMT2A Translocation
Read More
Disparities in Cancer Care, Oncology
IASLC Survey: Two Steps Forward, Two Steps Back in Lung Cancer Biomarker Testing
Read More
NCI Initiatives
About the NCI Equity and Inclusion Program
Read More
Online Only
In-Depth Drug Profile
Treatment Breakthrough Changes Cystic Fibrosis Landscape
Katherine E. Cilwa, PhD; Jayden Kim, PharmD
Read More
Disparities in Cancer Care, Oncology
Addressing Cancer Health Disparities: The No One Left Alone Initiative
Rohan Nathwani; Arva Patel; Warner Kornberg; Asutosh Gor, MD; Sashi Naidu, MD; Viral Rabara, MD; Niyati Nathwani, MD; Kashyap Patel, MD
Read More
Original Research
Provider and Payer Perspectives on the Impact of the COVID-19 Pandemic on Patients With Opioid Use Disorder: Multi-Stakeholder In-Depth Interviews
Maher Abdel-Sattar, PharmD, MS, FAMCP; Seth Cook, PharmD, MS; Ann Wheeler, PharmD; William Mullen, PA-C, MPH; Brett Alyson Maiese, PhD, MHS; Christian Heidbreder, PhD, MA; William Santoro, MD, FASAM, DABAM
Read More
Breast Cancer, Oncology
Radiation May Be Safely Omitted in Favorable-Risk Breast Cancer Patients Aged 50 to 69 Years
Read More
Online Only
Original Research, Practice Management, Health Policy and Reform
A Retrospective Trend Analysis of Utilization, Spending, and Prices for Generic Statins in the US Medicaid Population, 1991-2022
Yiyu Chen, MS; Patricia R. Wigle, PharmD, PhD; Orson Austin, MD; Jeff Jianfei Guo, BPharm, PhD
Read More
FDA Approvals
Iwilfin FDA Approved for Adults and Pediatric Patients with High-Risk Neuroblastoma
Read More
Page 2 of 37
Results 11 - 20 of 362